Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis

Author:

Komolafe Oluyemi1,Roberts Danielle2,Freeman Suzanne C3,Wilson Peter4,Sutton Alex J3,Cooper Nicola J3,Pavlov Chavdar S5,Milne Elisabeth Jane6,Hawkins Neil7,Cowlin Maxine8,Thorburn Douglas9,Davidson Brian R2,Tsochatzis Emmanuel9,Gurusamy Kurinchi Selvan25

Affiliation:

1. University College London; London UK

2. University College London; Division of Surgery and Interventional Science; London UK NW3 2PF

3. University of Leicester; Department of Health Sciences; University Road Leicester UK LE1 7RH

4. University College London Hospitals NHS Foundation Trust; Clinical Microbiology and Virology; 5th Floor Central 250 Euston Road London UK NW1 2PG

5. 'Sechenov' First Moscow State Medical University; Center for Evidence-Based Medicine; Pogodinskja st. 1\1 Moscow Russian Federation 119881

6. Coventry University; Centre for Trust, Peace and Social Relations; Coventry UK

7. University of Glasgow; HEHTA; University Ave Glasgow G12 8QQ Glasgow UK

8. PSC Support; PO Box 6945 London UK

9. Royal Free Hospital and the UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street London UK NW3 2QG

Publisher

Wiley

Subject

Pharmacology (medical)

Reference150 articles.

1. Combined norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis;Abdel Motelleb;Hepatology International,2016

2. Efficacy of rifaximin in prevention of recurrence of hepatic encephalopathy in patients with cirrhosis of liver;Ali;Journal of the College of Physicians and Surgeons Pakistan,2014

3. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis;Alvarez;Arquivos de Gastroenterologia,2005

4. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study;Assem;Hepatology International,2016

5. Rifaximin and propranolol combination therapy is more effective than propranolol monotherapy in the hepatic venous pressure gradient response and propranolol dose reduction-a pilot study;Baik;Journal of Hepatology,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3